Psychopathology: A Clinical Science Approach, Global Edition

Höfundur: Jill Hooley (Útgáfa: 19)
Psychopathology: A Clinical Science Approach, Global Edition

Kaup valmöguleikar

Psychopathology: A Clinical Science Approach (formerly Abnormal Psychology, 18th Edition) provides an engaging introduction to psychological disorders. Authors Jill Hooley and Matthew Nock focus on the individuals at the heart of the study of psychopathology. Their biopsychosocial approach helps you understand the holistic context in which all range of behaviors occur. The 19th Edition explores the impact of culture and the stigma of psychological disorders.

Nánar um bókina

Útgefandi
Pearson International Content
ISBN
9781292752853
Print ISBN
9781292485034
Format
ePub
Útgáfa
19
Höfundar
Jill Hooley
Tungumál
English
Útgefið
2025-07-17
Prent takmörkun á líftíma
100
Prent takmörkun
2
Afritunar takmörkun
2

Kaflar

  • Cover
  • Cover
  • About Revel and This Course
  • Copyright
  • Copyright
  • About This Course
  • About This Course
  • Content Highlights
  • About the Authors
  • 1: Psychopathology: Overview and Research Approaches
  • Introduction: Psychopathology: Overview and Research Approaches
  • 1.1: How Are Mental Disorders Defined?
  • 1.1: How Are Mental Disorders Defined?
  • 1.1.1: Indicators of Abnormality
  • 1.1.2: The DSM-5-TR and the Definition of Mental Disorder
  • 1.2: Classification and Diagnosis
  • 1.2: Classification and Diagnosis
  • 1.2.1: What Are the Disadvantages of Classification?
  • 1.2.2: How Can We Reduce Prejudicial Attitudes Toward People with Mental Disorders?
  • 1.3: Culture and Abnormality
  • 1.3: Culture and Abnormality
  • 1.4: How Common Are Mental Disorders?
  • 1.4: How Common Are Mental Disorders?
  • 1.4.1: Prevalence and Incidence
  • 1.4.2: Prevalence Estimates for Mental Health Disorders
  • 1.4.3: The Global Burden of Disease
  • 1.4.4: Treatment
  • 1.4.5: Mental Health Professionals
  • 1.5: Research Approaches in Psychopathology
  • 1.5: Research Approaches in Psychopathology
  • 1.6: Sources of Information
  • 1.6: Sources of Information
  • 1.6.1: Case Studies
  • 1.6.2: Self-Report Data
  • 1.6.3: Observational Approaches
  • 1.7: Forming and Testing Hypotheses
  • 1.7: Forming and Testing Hypotheses
  • 1.7.1: Sampling and Generalization
  • 1.7.2: Internal and External Validity
  • 1.7.3: Criterion and Comparison Groups
  • 1.8: Correlational Research Designs
  • 1.8: Correlational Research Designs
  • 1.8.1: Measuring Correlation
  • 1.8.2: Statistical Significance
  • 1.8.3: Effect Size
  • 1.8.4: Meta-Analysis
  • 1.8.5: Correlations and Causality
  • 1.8.6: Retrospective versus Prospective Strategies
  • 1.9: The Experimental Method in Psychopathology
  • 1.9: The Experimental Method in Psychopathology
  • 1.9.1: Studying the Efficacy of Therapy
  • 1.9.2: Single-Case Experimental Designs
  • 1.9.3: Animal Research
  • Unresolved Issues: Are We All Becoming Mentally Ill? The Expanding Horizons of Mental Disorder
  • Unresolved Issues: Are We All Becoming Mentally Ill? The Expanding Horizons of Mental Disorder
  • Summary: Psychopathology: Overview and Research Approaches
  • Summary: Psychopathology: Overview and Research Approaches
  • 2: Earliest Views of Psychopathology
  • Introduction: Earliest Views of Psychopathology
  • 2.1: The First Views of Psychopathology
  • 2.1: The First Views of Psychopathology
  • 2.1.1: Demonology, Gods, and Magic
  • 2.1.2: Hippocrates’ Early Medical Concepts
  • 2.1.3: Early Philosophical Conceptualizations of Psychopathology
  • 2.1.4: Early Chinese Conceptualizations of Psychopathology
  • 2.1.5: Views of Psychopathology During the Middle Ages
  • 2.2: Views of Psychopathology in the 1500s and 1600s
  • 2.2: Views of Psychopathology in the 1500s and 1600s
  • 2.2.1: The Resurgence of Scientific Questioning in Europe
  • 2.2.2: The Establishment of Early Asylums
  • 2.3: Humanitarian Reform
  • 2.3: Humanitarian Reform
  • 2.3.1: Pinel’s Experiment and Tuke's Work in England
  • 2.3.2: Rush and Moral Management in America
  • 2.3.3: Dix and the Mental Hygiene Movement
  • 2.4: Views of the Causes and Treatment of Psychopathology in the 1800s and 1900s
  • 2.4: Views of the Causes and Treatment of Psychopathology in the 1800s and 1900s
  • 2.4.1: Nineteenth Century Views of Psychopathology and the Increasing Role of Psychiatrists
  • 2.4.2: Mental Hospital Care in the Twentieth Century
  • 2.5: The Emergence of Modern Views of Psychopathology
  • 2.5: The Emergence of Modern Views of Psychopathology
  • 2.5.1: Biological Discoveries: Establishing the Link Between the Brain and Mental Disorders
  • 2.5.2: Development of a Classification System for Mental Disorders
  • 2.5.3: Development of the Psychological Basis of Mental Disorder
  • 2.5.4: The Evolution of Experimental Psychology
  • Unresolved Issues: Deinstitutionalization
  • Unresolved Issues: Deinstitutionalization
  • Summary: Earliest Views of Psychopathology
  • Summary: Earliest Views of Psychopathology
  • 3: Causal Factors and Viewpoints
  • Introduction: Causal Factors and Viewpoints
  • 3.1: Risk Factors and Causes of Psychopathology
  • 3.1: Risk Factors and Causes of Psychopathology
  • 3.1.1: Necessary, Sufficient, and Contributory Causes
  • 3.1.2: Feedback and Bidirectionality in Psychopathology
  • 3.1.3: Diathesis–Stress Models
  • 3.2: Perspectives to Understanding the Causes of Psychopathology
  • 3.2: Perspectives to Understanding the Causes of Psychopathology
  • 3.3: The Biological Perspective
  • 3.3: The Biological Perspective
  • 3.3.1: Genetic Vulnerabilities
  • 3.3.2: Brain Dysfunction and Neural Plasticity
  • 3.3.3: Imbalances of Neurotransmitters and Hormones
  • 3.3.4: Temperament
  • 3.3.5: The Impact of the Biological Viewpoint
  • 3.4: The Psychological Perspective
  • 3.4: The Psychological Perspective
  • 3.4.1: The Psychodynamic Perspective
  • 3.4.2: The Behavioral Perspective
  • 3.4.3: The Cognitive-Behavioral Perspective
  • 3.4.4: What the Adoption of a Perspective Does and Does Not Do
  • 3.5: The Social Perspective
  • 3.5: The Social Perspective
  • 3.5.1: Early Deprivation or Trauma
  • 3.5.2: Problems in Parenting Style
  • 3.5.3: Marital Discord and Divorce
  • 3.5.4: Low Socioeconomic Status and Unemployment
  • 3.5.5: Maladaptive Peer Relationships
  • 3.5.6: Prejudice and Discrimination in Race, Gender, and Ethnicity
  • 3.5.7: The Impact of the Social Perspective
  • 3.6: The Cultural Perspective
  • 3.6: The Cultural Perspective
  • Unresolved Issues: Theoretical Perspectives and the Causes of Psychopathology
  • Unresolved Issues: Theoretical Perspectives and the Causes of Psychopathology
  • Summary: Causal Factors and Viewpoints
  • Summary: Causal Factors and Viewpoints
  • 4: Clinical Assessment and Diagnosis
  • Introduction: Clinical Assessment and Diagnosis
  • 4.1: Three Fundamental Concepts
  • 4.1: Three Fundamental Concepts
  • 4.1.1: Reliability
  • 4.1.2: Validity
  • 4.1.3: Standardization
  • 4.2: The Nature and Goals of Assessment
  • 4.2: The Nature and Goals of Assessment
  • 4.3: Important Factors Influencing Assessment
  • 4.3: Important Factors Influencing Assessment
  • 4.3.1: Ensuring Culturally Sensitive Assessment Procedures
  • 4.3.2: The Influence of Professional Orientation
  • 4.3.3: Trust and Rapport Between the Clinician and the Client
  • 4.4: Methods of Psychosocial Assessment
  • 4.4: Methods of Psychosocial Assessment
  • 4.4.1: Clinical Interviews
  • 4.4.2: The Clinical Observation of Behavior
  • 4.4.3: Psychological Tests
  • 4.5: Physical Assessment
  • 4.5: Physical Assessment
  • 4.5.1: Physical Examination
  • 4.5.2: The Neuropsychological Examination
  • 4.5.3: Neurological Approaches to Assessment
  • 4.6: Integrating Assessment Data and Optimizing Decision Making
  • 4.6: Integrating Assessment Data and Optimizing Decision Making
  • 4.7: Classifying Maladaptive Behavior
  • 4.7: Classifying Abnormal Behavior
  • 4.7.1: Approaches to Classification
  • 4.7.2: Formal Diagnostic Classification of Mental Disorders
  • Unresolved Issues: The DSM-5: A Change for the Better?
  • Unresolved Issues: The DSM-5: A Change for the Better?
  • Summary: Clinical Assessment and Diagnosis
  • Summary: Clinical Assessment and Diagnosis
  • 5: Stress and Physical and Mental Health
  • Introduction: Stress and Physical and Mental Health
  • 5.1: What Is Stress?
  • 5.1: What Is Stress?
  • 5.1.1: Stress and the DSM
  • 5.1.2: Factors Predisposing a Person to Stress
  • 5.1.3: Characteristics of Stressors
  • 5.1.4: Measuring Life Stress
  • 5.1.5: Resilience
  • 5.2: Stress and Physical Health
  • 5.2: Stress and Physical Health
  • 5.2.1: The Stress Response
  • 5.2.2: The Mind–Body Connection
  • 5.2.3: Understanding the Immune System
  • 5.3: Stress and Immune System Functioning
  • 5.3: Stress and Immune System Functioning
  • 5.3.1: Stress and Cytokines
  • 5.3.2: Chronic Stress and Inflammation
  • 5.3.3: Stress and Premature Aging
  • 5.4: Emotions and Health
  • 5.4: Emotions and Health
  • 5.4.1: Personality
  • 5.4.2: Depression
  • 5.4.3: Anxiety
  • 5.4.4: Social Isolation and Lack of Social Support
  • 5.4.5: Positive Emotions
  • 5.4.6: The Importance of Emotion Regulation
  • 5.5: Treatment of Stress-Related Physical Disorders
  • 5.5: Treatment of Stress-Related Physical Disorders
  • 5.5.1: Biological Interventions
  • 5.5.2: Psychological Interventions
  • 5.6: Stress and Mental Health
  • 5.6: Stress and Mental Health
  • 5.6.1: Adjustment Disorder
  • 5.6.2: Adjustment Disorder Caused by Unemployment
  • 5.6.3: Posttraumatic Stress Disorder
  • 5.6.4: Acute Stress Disorder
  • 5.7: Posttraumatic Stress Disorder: Causes and Risk Factors
  • 5.7: Posttraumatic Stress Disorder: Causes and Risk Factors
  • 5.7.1: Prevalence of PTSD in the General Population
  • 5.7.2: Rates of PTSD after Traumatic Experiences
  • 5.7.3: Causal Factors in Posttraumatic Stress Disorder
  • 5.7.4: Individual Risk Factors
  • 5.7.5: Biological Factors
  • 5.7.6: Sociocultural Factors
  • 5.7.7: Long-Term Effects of Posttraumatic Stress
  • 5.8: Prevention and Treatment of Stress Disorders
  • 5.8: Prevention and Treatment of Stress Disorders
  • 5.8.1: Prevention
  • 5.8.2: Treatment for Stress Disorders
  • 5.8.3: Trauma and Physical Health
  • Unresolved Issues: Why Is the Study of Trauma So Contentious?
  • Unresolved Issues: Why Is the Study of Trauma So Contentious?
  • Case Study: PTSD
  • Case Study: PTSD
  • Summary: Stress and Physical and Mental Health
  • Summary: Stress and Physical and Mental Health
  • 6: Panic, Anxiety, Obsessions, and Their Disorders
  • Introduction: Panic, Anxiety, Obsessions, and Their Disorders
  • 6.1: The Fear and Anxiety Response Patterns
  • 6.1: The Fear and Anxiety Response Patterns
  • 6.1.1: Fear
  • 6.1.2: Anxiety
  • 6.2: Overview of the Anxiety Disorders and Their Commonalities
  • 6.2: Overview of the Anxiety Disorders and Their Commonalities
  • 6.3: Specific Phobias
  • 6.3: Specific Phobias
  • 6.3.1: Prevalence, Age of Onset, and Gender Differences
  • 6.3.2: Psychological Causal Factors
  • 6.3.3: Biological Causal Factors
  • 6.3.4: Treatments
  • 6.4: Social Anxiety Disorder
  • 6.4: Social Anxiety Disorder
  • 6.4.1: Prevalence, Age of Onset, and Sex Differences
  • 6.4.2: Psychological Causal Factors
  • 6.4.3: Biological Causal Factors
  • 6.4.4: Treatments
  • 6.5: Panic Disorder
  • 6.5: Panic Disorder
  • 6.5.1: Agoraphobia
  • 6.5.2: Prevalence, Age of Onset, and Sex Differences
  • 6.5.3: Comorbidity with Other Disorders
  • 6.5.4: The Timing of a First Panic Attack
  • 6.5.5: Biological Causal Factors
  • 6.5.6: Psychological Causal Factors
  • 6.5.7: Treatments
  • 6.6: Generalized Anxiety Disorder
  • 6.6: Generalized Anxiety Disorder
  • 6.6.1: Prevalence, Age of Onset, and Sex Differences
  • 6.6.2: Comorbidity with Other Disorders
  • 6.6.3: Psychological Causal Factors
  • 6.6.4: Biological Causal Factors
  • 6.6.5: Treatments
  • 6.7: Obsessive-Compulsive and Related Disorders
  • 6.7: Obsessive-Compulsive and Related Disorders
  • 6.7.1: Obsessive-Compulsive Disorder
  • 6.7.2: Prevalence, Age of Onset, and Gender Differences
  • 6.7.3: Comorbidity with Other Disorders
  • 6.7.4: Psychological Causal Factors
  • 6.7.5: Biological Causal Factors
  • 6.7.6: Treatments
  • 6.7.7: Body Dysmorphic Disorder
  • 6.7.8: Hoarding Disorder
  • 6.7.9: Trichotillomania
  • 6.8: Cultural Perspectives
  • 6.8: Cultural Perspectives
  • Unresolved Issues: The Choice of Treatments: Medication or Cognitive-Behavior Therapy?
  • Unresolved Issues: The Choice of Treatments: Medication or Cognitive-Behavior Therapy?
  • Case Study: Agoraphobia and Panic
  • Case Study: Agoraphobia and Panic
  • Case Study: Hoarding
  • Case Study: Hoarding
  • Summary: Panic, Anxiety, Obsessions, and Their Disorders
  • Summary: Panic, Anxiety, Obsessions, and Their Disorders
  • 7: Mood Disorders and Suicide
  • Introduction: Mood Disorders and Suicide
  • 7.1: Mood Disorders: An Overview
  • 7.1: Mood Disorders: An Overview
  • 7.1.1: Types of Mood Disorders
  • 7.1.2: The Prevalence of Mood Disorders
  • 7.2: Unipolar Depressive Disorders
  • 7.2: Unipolar Depressive Disorders
  • 7.2.1: Major Depressive Disorder
  • 7.2.2: Persistent Depressive Disorder
  • 7.2.3: Other Forms of Depression
  • 7.3: Causal Factors in Unipolar Mood Disorders
  • 7.3: Causal Factors in Unipolar Mood Disorders
  • 7.3.1: Biological Causal Factors
  • 7.3.2: Psychological Causal Factors
  • 7.4: Bipolar and Related Disorders
  • 7.4: Bipolar and Related Disorders
  • 7.4.1: Cyclothymic Disorder
  • 7.4.2: Bipolar Disorders (I and II)
  • 7.5: Causal Factors in Bipolar Disorders
  • 7.5: Causal Factors in Bipolar Disorders
  • 7.5.1: Biological Causal Factors
  • 7.5.2: Psychological Causal Factors
  • 7.6: Sociocultural Factors Affecting Unipolar and Bipolar Disorders
  • 7.6: Sociocultural Factors Affecting Unipolar and Bipolar Disorders
  • 7.6.1: Cross-Cultural Differences in Depressive Symptoms
  • 7.6.2: Cross-Cultural Differences in Prevalence
  • 7.7: Treatments and Outcomes
  • 7.7: Treatments and Outcomes
  • 7.7.1: Pharmacotherapy
  • 7.7.2: Alternative Biological Treatments
  • 7.7.3: Psychotherapy
  • 7.8: Suicide: The Clinical Picture and the Causal Pattern
  • 7.8: Suicide: The Clinical Picture and the Causal Pattern
  • 7.8.1: Who Attempts and Dies by Suicide?
  • 7.8.2: Psychological Disorders
  • 7.8.3: Other Psychosocial Factors Associated with Suicide
  • 7.8.4: Biological Factors
  • 7.8.5: Theoretical Models of Suicidal Behavior
  • 7.9: Suicide Prevention and Intervention
  • 7.9: Suicide Prevention and Intervention
  • 7.9.1: Treatment of Mental Disorders
  • 7.9.2: Crisis Intervention
  • 7.9.3: Focus on High-Risk Groups and Other Measures
  • Unresolved Issues: Is There a Right to Die?
  • Unresolved Issues: Is There a Right to Die?
  • Case Study: Bipolar Disorder
  • Case Study: Bipolar Disorder
  • Summary: Mood Disorders and Suicide
  • Summary: Mood Disorders and Suicide
  • DSM-5-TR Criteria for Bipolar I Disorder
  • DSM-5-TR Criteria for Bipolar I Disorder
  • 8: Somatic Symptom and Dissociative Disorders
  • Introduction: Somatic Symptom and Dissociative Disorders
  • 8.1: Somatic Symptom and Related Disorders: An Overview
  • 8.1: Somatic Symptom and Related Disorders: An Overview
  • 8.2: Somatic Symptom Disorder
  • 8.2: Somatic Symptom Disorder
  • 8.2.1: Causes of Somatic Symptom Disorder
  • 8.2.2: Treatment of Somatic Symptom Disorder
  • 8.3: Illness Anxiety Disorder
  • 8.3: Illness Anxiety Disorder
  • 8.4: Functional Neurological Symptom Disorder (Conversion Disorder)
  • 8.4: Functional Neurological Symptom Disorder (Conversion Disorder)
  • 8.4.1: Range of Functional Neurological Symptom Disorder Symptoms
  • 8.4.2: Important Issues in Diagnosing Functional Neurological Symptom Disorder
  • 8.4.3: Prevalence and Demographic Characteristics
  • 8.4.4: Causes of Functional Neurological Symptom Disorders
  • 8.4.5: Treatment of Functional Neurological Symptom Disorders
  • 8.5: Factitious Disorder
  • 8.5: Factitious Disorder
  • 8.5.1: Identifying Factitious Disorder
  • 8.5.2: Distinguishing Between Different Types of Somatic Symptom and Related Disorders
  • 8.6: Dissociative Disorders: An Overview
  • 8.6: Dissociative Disorders: An Overview
  • 8.7: Depersonalization/Derealization Disorder
  • 8.7: Depersonalization/Derealization Disorder
  • 8.8: Dissociative Amnesia
  • 8.8: Dissociative Amnesia
  • 8.9: Dissociative Identity Disorder
  • 8.9: Dissociative Identity Disorder
  • 8.9.1: Causal Factors and Controversies about DID
  • 8.9.2: Current Perspectives
  • 8.10: Cultural Factors, Treatments, and Outcomes in Dissociative Disorders
  • 8.10: Cultural Factors, Treatments, and Outcomes in Dissociative Disorders
  • 8.10.1: Cultural Factors in Dissociative Disorders
  • 8.10.2: Treatment and Outcomes in Dissociative Disorders
  • Unresolved Issues: DID and the Reality of "Recovered Memories"
  • Unresolved Issues: DID and the Reality of “Recovered Memories”
  • Case Study: Factitious Disorder
  • Case Study: Factitious Disorder
  • Summary: Somatic Symptom and Dissociative Disorders
  • Summary: Somatic Symptom and Dissociative Disorders
  • 9: Eating Disorders and Obesity
  • Introduction: Eating Disorders and Obesity
  • 9.1: Clinical Aspects of Eating Disorders
  • 9.1: Clinical Aspects of Eating Disorders
  • 9.1.1: Anorexia Nervosa
  • 9.1.2: Bulimia Nervosa
  • 9.1.3: Binge-Eating Disorder
  • 9.1.4: Age of Onset and Sex and Gender Differences
  • 9.1.5: Prevalence of Eating Disorders
  • 9.1.6: Medical Complications of Eating Disorders
  • 9.1.7: Course and Outcome
  • 9.1.8: Diagnostic Crossover
  • 9.1.9: Association of Eating Disorders with Other Forms of Psychopathology
  • 9.1.10: Eating Disorders Across Cultures
  • 9.2: Risk and Causal Factors in Eating Disorders
  • 9.2: Risk and Causal Factors in Eating Disorders
  • 9.2.1: Biological Factors
  • 9.2.2: Sociocultural Context
  • 9.2.3: Family Influences
  • 9.2.4: Individual Risk Factors
  • 9.3: Treatment of Eating Disorders
  • 9.3: Treatment of Eating Disorders
  • 9.3.1: Treatment of Anorexia Nervosa
  • 9.3.2: Treatment of Bulimia Nervosa
  • 9.3.3: Treatment of Binge-Eating Disorder
  • 9.4: The Problem of Obesity
  • 9.4: The Problem of Obesity
  • 9.4.1: Medical Issues and Prevalence
  • 9.4.2: Weight Stigma
  • 9.4.3: Obesity and the DSM
  • 9.5: Risk and Causal Factors in Obesity
  • 9.5: Risk and Causal Factors in Obesity
  • 9.5.1: The Role of Genes
  • 9.5.2: Hormones Involved in Appetite and Weight Regulation
  • 9.5.3: Sociocultural Influences
  • 9.5.4: Family Influences
  • 9.5.5: Stress and “Comfort Food”
  • 9.5.6: Pathways to Obesity
  • 9.6: Treatment of Obesity
  • 9.6: Treatment of Obesity
  • 9.6.1: Lifestyle Modifications
  • 9.6.2: Medications
  • 9.6.3: Bariatric Surgery
  • 9.6.4: The Importance of Prevention
  • Unresolved Issues: The Role of Public Policy in the Prevention of Obesity
  • Unresolved Issues: The Role of Public Policy in the Prevention of Obesity
  • Case Study: Binge-Eating Disorder
  • Case Study: Binge-Eating Disorder
  • Summary: Eating Disorders and Obesity
  • Summary: Eating Disorders and Obesity
  • 10: Personality Disorders
  • Introduction: Personality Disorders
  • 10.1: Clinical Features of Personality Disorders
  • 10.1: Clinical Features of Personality Disorders
  • 10.2: Challenges in Personality Disorders Research
  • 10.2: Challenges in Personality Disorders Research
  • 10.2.1: Difficulties in Diagnosing Personality Disorders
  • 10.2.2: Difficulties in Studying the Causes of Personality Disorders
  • 10.3: Cluster A Personality Disorders
  • 10.3: Cluster A Personality Disorders
  • 10.3.1: Paranoid Personality Disorder
  • 10.3.2: Schizoid Personality Disorder
  • 10.3.3: Schizotypal Personality Disorder
  • 10.4: Cluster B Personality Disorders
  • 10.4: Cluster B Personality Disorders
  • 10.4.1: Histrionic Personality Disorder
  • 10.4.2: Narcissistic Personality Disorder
  • 10.4.3: Antisocial Personality Disorder
  • 10.4.4: Borderline Personality Disorder
  • 10.5: Cluster C Personality Disorders
  • 10.5: Cluster C Personality Disorders
  • 10.5.1: Avoidant Personality Disorder
  • 10.5.2: Dependent Personality Disorder
  • 10.5.3: Obsessive-Compulsive Personality Disorder
  • 10.6: General Sociocultural Causal Factors for Personality Disorders
  • 10.6: General Sociocultural Causal Factors for Personality Disorders
  • 10.7: Treatments and Outcomes for Personality Disorders
  • 10.7: Treatments and Outcomes for Personality Disorders
  • 10.7.1: Adapting Therapeutic Techniques to Specific Personality Disorders
  • 10.7.2: Treating Borderline Personality Disorder
  • 10.7.3: Treating Other Personality Disorders
  • 10.8: Psychopathy
  • 10.8: Psychopathy
  • 10.8.1: Dimensions of Psychopathy
  • 10.8.2: The Clinical Picture in Psychopathy
  • 10.8.3: Causal Factors in Psychopathy
  • 10.8.4: Developmental and Social Perspectives on Psychopathy
  • 10.8.5: Treatments and Outcomes in Psychopathic Personality
  • Unresolved Issues: DSM-5-TR: How Can We Improve the Classification of Personality Disorders?
  • Unresolved Issues: DSM-5-TR: How Can We Improve the Classification of Personality Disorders?
  • Case Study: Narcissistic Personality Disorder
  • Case Study: Narcissistic Personality Disorder
  • Summary: Personality Disorders
  • Summary: Personality Disorders
  • 11: Substance-Related Disorders
  • Introduction: Substance-Related Disorders
  • 11.1: Alcohol-Related Disorders
  • 11.1: Alcohol-Related Disorders
  • 11.1.1: The Prevalence, Comorbidity, and Demographics of Alcohol Use Disorder
  • 11.1.2: The Clinical Picture of Alcohol-Related Disorders
  • 11.2: Causal Factors in Alcohol Use Disorder
  • 11.2: Causal Factors in Alcohol Use Disorder
  • 11.2.1: Biological Causal Factors in Alcohol Use Disorder
  • 11.2.2: Psychosocial Causal Factors in Alcohol Abuse and Dependence
  • 11.2.3: Sociocultural Causal Factors
  • 11.3: Treatment of Alcohol-Related Disorders
  • 11.3: Treatment of Alcohol-Related Disorders
  • 11.3.1: Use of Medications in Treating Alcohol Use Disorders
  • 11.3.2: Psychological Treatment Approaches
  • 11.3.3: Controlled Drinking versus Abstinence
  • 11.3.4: Alcoholics Anonymous
  • 11.3.5: Outcome Studies and Issues in Treatment
  • 11.3.6: Relapse Prevention
  • 11.4: Substance Use Disorder
  • 11.4: Substance Use Disorder
  • 11.5: Opium and Its Derivatives
  • 11.5: Opium and Its Derivatives
  • 11.5.1: Biological Effects of Morphine and Heroin
  • 11.5.2: Social Effects of Morphine and Heroin
  • 11.5.3: Causal Factors in Opiate Abuse and Dependence
  • 11.5.4: Neural Bases for Physiological Addiction
  • 11.5.5: Addiction Associated with Psychopathology
  • 11.5.6: Treatments and Outcomes
  • 11.6: Stimulants
  • 11.6: Stimulants
  • 11.6.1: Cocaine
  • 11.6.2: Amphetamines
  • 11.6.3: Methamphetamine
  • 11.6.4: Caffeine and Nicotine
  • 11.7: Sedatives
  • 11.7: Sedatives
  • 11.7.1: Effects of Barbiturates
  • 11.7.2: Causal Factors in Barbiturate Abuse and Dependence
  • 11.7.3: Treatments and Outcomes
  • 11.8: Hallucinogens
  • 11.8: Hallucinogens
  • 11.8.1: LSD
  • 11.8.2: Mescaline and Psilocybin
  • 11.8.3: MDMA
  • 11.8.4: Marijuana
  • 11.9: Gambling Disorder
  • 11.9: Gambling Disorder
  • Unresolved Issues: Exchanging Addictions: Is This an Effective Treatment Approach?
  • Unresolved Issues: Exchanging Addictions: Is This an Effective Treatment Approach?
  • Case Study: Gambling Disorder
  • Case Study: Gambling Disorder
  • Summary: Substance-Related Disorders
  • Summary: Substance-Related Disorders
  • 12: Gender Dysphoria, Sexual Dysfunctions, and Paraphilic Disorders
  • Introduction: Gender Dysphoria, Sexual Dysfunctions, and Paraphilic Disorders
  • 12.1: Gender Identity and Gender Dysphoria
  • 12.1: Gender Identity and Gender Dysphoria
  • 12.1.1: The Clinical Picture
  • 12.1.2: Treatment for Gender Dysphoria
  • 12.2: Sexual Dysfunctions
  • 12.2: Sexual Dysfunctions
  • 12.3: Sexual Dysfunctions in Males
  • 12.3: Sexual Dysfunctions in Males
  • 12.3.1: Male Hypoactive Sexual Desire Disorder
  • 12.3.2: Erectile Disorder
  • 12.3.3: Premature (Early) Ejaculation
  • 12.3.4: Delayed Ejaculation Disorder
  • 12.4: Sexual Dysfunctions in Females
  • 12.4: Sexual Dysfunctions in Females
  • 12.4.1: Female Sexual Interest/Arousal Disorder
  • 12.4.2: Genito-Pelvic Pain/Penetration Disorder
  • 12.4.3: Female Orgasmic Disorder
  • 12.5: Paraphilic Disorders
  • 12.5: Paraphilic Disorders
  • 12.5.1: Voyeuristic Disorder
  • 12.5.2: Exhibitionistic Disorder
  • 12.5.3: Frotteuristic Disorder
  • 12.5.4: Sexual Sadism Disorder
  • 12.5.5: Sexual Masochism Disorder
  • 12.5.6: Fetishistic Disorder
  • 12.5.7: Transvestic Disorder
  • 12.5.8: Causal Factors and Treatments for Paraphilic Disorders
  • 12.6: Sexual Abuse
  • 12.6: Sexual Abuse
  • 12.6.1: Childhood Sexual Abuse
  • 12.6.2: Pedophilic Disorder
  • 12.6.3: Incest
  • 12.6.4: Rape
  • 12.6.5: Treatment and Recidivism of Sex Offenders
  • Unresolved Issues: How Harmful Is Childhood Sexual Abuse?
  • Unresolved Issues: How Harmful Is Childhood Sexual Abuse?
  • Case Study: Fetishistic Disorder
  • Case Study: Fetishistic Disorder
  • Summary: Gender Dysphoria, Sexual Dysfunctions, and Paraphilic Disorders
  • Summary: Gender Dysphoria, Sexual Dysfunctions, and Paraphilic Disorders
  • DSM-5-TR Criteria for Gender Dysphoria, Sexual Dysfunctions, and Paraphilic Disorders
  • DSM-5-TR Criteria for Gender Dysphoria, Sexual Dysfunctions, and Paraphilic Disorders
  • 13: Schizophrenia and Other Psychotic Disorders
  • Introduction: Schizophrenia and Other Psychotic Disorders
  • 13.1: Schizophrenia
  • 13.1: Schizophrenia
  • 13.1.1: Origins of the Schizophrenia Construct
  • 13.1.2: Epidemiology
  • 13.2: Clinical Picture
  • 13.2: Clinical Picture
  • 13.2.1: Delusions
  • 13.2.2: Hallucinations
  • 13.2.3: Disorganized Speech
  • 13.2.4: Disorganized Behavior
  • 13.2.5: Negative Symptoms
  • 13.3: Other Psychotic Disorders
  • 13.3: Other Psychotic Disorders
  • 13.3.1: Schizoaffective Disorder
  • 13.3.2: Schizophreniform Disorder
  • 13.3.3: Delusional Disorder
  • 13.3.4: Brief Psychotic Disorder
  • 13.4: Genetic and Biological Factors
  • 13.4: Genetic and Biological Factors
  • 13.4.1: Genetic Factors
  • 13.4.2: Prenatal Exposures
  • 13.4.3: Genes and Environment in Schizophrenia: A Synthesis
  • 13.4.4: A Neurodevelopmental Perspective
  • 13.5: Structural and Functional Brain Abnormalities
  • 13.5: Structural and Functional Brain Abnormalities
  • 13.5.1: Neurocognition
  • 13.5.2: Social Cognition
  • 13.5.3: Loss of Brain Volume
  • 13.5.4: Affected Brain Areas
  • 13.5.5: White Matter Problems
  • 13.5.6: Brain Functioning
  • 13.5.7: Cytoarchitecture
  • 13.5.8: Brain Development in Adolescence
  • 13.5.9: Synthesis
  • 13.5.10: Neurochemistry
  • 13.6: Psychosocial and Cultural Factors
  • 13.6: Psychosocial and Cultural Factors
  • 13.6.1: Do Bad Families Cause Schizophrenia?
  • 13.6.2: Families and Relapse
  • 13.6.3: Urban Living
  • 13.6.4: Immigration
  • 13.6.5: Cannabis Use and Abuse
  • 13.6.6: A Diathesis–Stress Model of Schizophrenia
  • 13.7: Treatments and Outcomes
  • 13.7: Treatments and Outcomes
  • 13.7.1: Clinical Outcome
  • 13.7.2: Pharmacological Approaches
  • 13.7.3: Psychosocial Approaches
  • Thinking Like a Clinician
  • Thinking Like a Clinician
  • Unresolved Issues: Why Are Recovery Rates in Schizophrenia Not Improving?
  • Unresolved Issues: Why Are Recovery Rates in Schizophrenia Not Improving?
  • Case Study: Schizophrenia
  • Case Study: Schizophrenia
  • Case Study: Delusional Disorder
  • Case Study: Delusional Disorder
  • Summary: Schizophrenia and Other Psychotic Disorders
  • Summary: Schizophrenia and Other Psychotic Disorders
  • 14: Neurocognitive Disorders
  • Introduction: Neurocognitive Disorders
  • 14.1: Brain Impairment in Adults
  • 14.1: Brain Impairment in Adults
  • 14.1.1: Clinical Signs of Brain Damage
  • 14.1.2: Diffuse versus Focal Damage
  • 14.1.3: The Neurocognitive/Psychopathology Interaction
  • 14.2: Delirium
  • 14.2: Delirium
  • 14.2.1: Clinical Picture
  • 14.2.2: Treatments and Outcomes
  • 14.3: Major Neurocognitive Disorder
  • 14.3: Major Neurocognitive Disorder
  • 14.3.1: Parkinson’s Disease
  • 14.3.2: Huntington’s Disease
  • 14.4: Alzheimer’s Disease
  • 14.4: Alzheimer’s Disease
  • 14.4.1: Clinical Picture
  • 14.4.2: Prevalence
  • 14.4.3: Causal Factors
  • 14.4.4: Neuropathology
  • 14.4.5: Treatment and Outcome
  • 14.4.6: Early Detection
  • 14.4.7: Supporting Caregivers
  • 14.5: Neurocognitive Disorder Resulting from Vascular Problems
  • 14.5: Neurocognitive Disorder Resulting from Vascular Problems
  • 14.6: Neurocognitive Disorder Characterized by Profound Memory Impairment (Amnestic Disorder)
  • 14.6: Neurocognitive Disorder Characterized by Profound Memory Impairment (Amnestic Disorder)
  • 14.7: Disorders Involving Head Injury
  • 14.7: Disorders Involving Head Injury
  • 14.7.1: Clinical Picture
  • 14.7.2: Treatments and Outcomes
  • Unresolved Issues: Should Healthy People Use Cognitive Enhancers?
  • Unresolved Issues: Should Healthy People Use Cognitive Enhancers?
  • Case Study: Delirium
  • Case Study: Delirium
  • Summary: Neurocognitive Disorders
  • Summary: Neurocognitive Disorders
  • 15: Disorders of Childhood and Adolescence (Neurodevelopmental Disorders)
  • Introduction: Disorders of Childhood and Adolescence (Neurodevelopmental Disorders)
  • 15.1: Special Considerations in Understanding Disorders of Childhood and Adolescence
  • 15.1: Special Considerations in Understanding Disorders of Childhood and Adolescence
  • 15.1.1: Psychological Vulnerabilities of Young Children
  • 15.1.2: The Classification of Childhood and Adolescent Disorders
  • 15.2: Anxiety and Depression in Children and Adolescents
  • 15.2: Anxiety and Depression in Children and Adolescents
  • 15.2.1: Anxiety Disorders of Childhood and Adolescence
  • 15.2.2: Childhood Depression and Bipolar Disorder
  • 15.3: Disruptive, Impulse-Control, and Conduct Disorder
  • 15.3: Disruptive, Impulse-Control, and Conduct Disorder
  • 15.3.1: Oppositional Defiant Disorder
  • 15.3.2: Conduct Disorder
  • 15.3.3: Causal Factors in ODD and CD
  • 15.3.4: Treatments and Outcomes
  • 15.4: Elimination Disorders
  • 15.4: Elimination Disorders
  • 15.4.1: Enuresis
  • 15.4.2: Encopresis
  • 15.5: Neurodevelopmental Disorders
  • 15.5: Neurodevelopmental Disorders
  • 15.5.1: Attention-Deficit/Hyperactivity Disorder
  • 15.5.2: Autism Spectrum Disorder
  • 15.5.3: Tic Disorders
  • 15.6: Specific Learning Disorders
  • 15.6: Specific Learning Disorders
  • 15.6.1: Causal Factors in Learning Disorders
  • 15.6.2: Treatments and Outcomes
  • 15.7: Intellectual Developmental Disorder (Intellectual Disability)
  • 15.7: Intellectual Developmental Disorder (Intellectual Disability)
  • 15.7.1: Levels of Intellectual Developmental Disorder
  • 15.7.2: Causal Factors in Intellectual Developmental Disorder
  • 15.7.3: Organic Intellectual Developmental Disorder Syndromes
  • 15.7.4: Treatments, Outcomes, and Prevention
  • 15.8: Special Considerations in the Treatment of Children and Adolescents
  • 15.8: Special Considerations in the Treatment of Children and Adolescents
  • 15.8.1: Special Factors Associated with Treatment of Children and Adolescents
  • 15.8.2: Childhood Advocacy Programs
  • Unresolved Issues: How Should Society Deal with Delinquent Behavior?
  • Unresolved Issues: How Should Society Deal with Delinquent Behavior?
  • Case Study: Conduct Disorder
  • Case Study: Conduct Disorder
  • Summary: Disorders of Childhood and Adolescence (Neurodevelopmental Disorders)
  • Summary: Disorders of Childhood and Adolescence (Neurodevelopmental Disorders)
  • 16: Psychological Treatment
  • Introduction: Psychological Treatment
  • 16.1: An Overview of Treatment
  • 16.1: An Overview of Treatment
  • 16.1.1: Why Do People Seek Therapy?
  • 16.1.2: Who Provides Psychotherapeutic Services?
  • 16.1.3: The Therapeutic Relationship
  • 16.2: Measuring Success in Psychotherapy
  • 16.2: Measuring Success in Psychotherapy
  • 16.2.1: Objectifying and Quantifying Change
  • 16.2.2: Would Change Occur Anyway?
  • 16.2.3: Can Therapy Be Harmful?
  • 16.3: What Therapeutic Approaches Should Be Used?
  • 16.3: What Therapeutic Approaches Should Be Used?
  • 16.3.1: Evidence-Based Treatment
  • 16.3.2: Medication or Psychotherapy?
  • 16.3.3: Combined Treatments
  • 16.4: Psychosocial Approaches to Treatment
  • 16.4: Psychosocial Approaches to Treatment
  • 16.4.1: Behavior Therapy
  • 16.4.2: Cognitive and Cognitive-Behavioral Therapy
  • 16.4.3: Humanistic-Experiential Therapies
  • 16.4.4: Psychodynamic Therapies
  • 16.4.5: Couples and Family Therapy
  • 16.4.6: Eclecticism and Integration
  • 16.4.7: Rebooting Psychotherapy
  • 16.5: Sociocultural Perspectives
  • 16.5: Sociocultural Perspectives
  • 16.5.1: Social Values and Psychotherapy
  • 16.5.2: Psychotherapy and Cultural Diversity
  • 16.6: Biological Approaches to Treatment
  • 16.6: Biological Approaches to Treatment
  • 16.6.1: Antipsychotic Drugs
  • 16.6.2: Antidepressant Drugs
  • 16.6.3: Antianxiety Drugs
  • 16.6.4: Lithium and Other Mood-Stabilizing Drugs
  • 16.6.5: Nonmedicinal Biological Treatments
  • Unresolved Issues: Do Psychiatric Medications Help or Harm?
  • Unresolved Issues: Do Psychiatric Medications Help or Harm?
  • Case Study: Treatment
  • Case Study: Treatment
  • Summary: Psychological Treatment
  • Summary: Psychological Treatment
  • 17: Societal and Legal Issues in Psychopathology
  • Introduction: Societal and Legal Issues in Psychopathology
  • 17.1: Perspectives on Prevention
  • 17.1: Perspectives on Prevention
  • 17.1.1: Universal Interventions
  • 17.1.2: Selective Interventions
  • 17.1.3: Indicated Interventions
  • 17.2: Inpatient Mental Health Treatment
  • 17.2: Inpatient Mental Health Treatment
  • 17.2.1: The Mental Hospital as a Therapeutic Community
  • 17.2.2: Aftercare Programs
  • 17.3: Involuntary Commitment
  • 17.3: Involuntary Commitment
  • 17.3.1: Civil Commitment
  • 17.3.2: Assessment of “Dangerousness”
  • 17.4: Therapists and the Duty to Warn
  • 17.4: Therapists and the Duty to Warn
  • 17.5: Patients’ Rights
  • 17.5: Patients’ Rights
  • 17.6: The Insanity Defense
  • 17.6: The Insanity Defense
  • 17.6.1: Notable NGRI Cases
  • 17.6.2: What Exactly Do We Mean by Insanity?
  • 17.6.3: Competence to Stand Trial
  • 17.6.4: Mental Health Problems and Recidivism
  • 17.7: Organized Efforts for Mental Health
  • 17.7: Organized Efforts for Mental Health
  • 17.7.1: The Federal Government and Mental Health
  • 17.7.2: Professional Organizations and Mental Health
  • 17.7.3: The Role of Volunteer Organizations and Agencies
  • 17.7.4: Mental Health Resources in Private Industry
  • 17.8: Challenges for the Future
  • 17.8: Challenges for the Future
  • 17.8.1: The Need for Planning
  • 17.8.2: The Individual’s Contribution
  • Unresolved Issues: What Is the Goldwater Rule and Why Is It Important Now?
  • Unresolved Issues: What Is the Goldwater Rule and Why Is It Important Now?
  • Case Study: James Holmes
  • Case Study: James Holmes
  • Summary: Societal and Legal Issues in Abnormal Psychology
  • Summary: Societal and Legal Issues in Abnormal Psychology
  • References
  • References
  • References
  • Footnotes
  • Glossary